What Researchers Did
A prospective study evaluated the effectiveness of hyperbaric oxygen therapy (HBO2) in 38 patients with non-arteritic central retinal artery occlusion (CRAO).
What They Found
Overall, patients experienced a mean improvement of 0.5 logMAR in visual acuity, from 2.2 to 1.7 logMAR (p=0.0003), after HBO2 therapy. This improvement was more pronounced when HBO2 was initiated earlier, with a 0.9 logMAR improvement if treatment began within eight hours of symptom onset.
What This Means for Canadian Patients
Canadian patients experiencing sudden vision loss due to central retinal artery occlusion might benefit from hyperbaric oxygen therapy. Early presentation to a facility offering HBO2 could significantly improve their visual outcomes.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
The study was limited by its relatively small sample size and the need for further research to determine long-term outcomes and optimal treatment protocols.